Using the specific GSK3α/β inhibitor SB 216763 we comprehensively investigated the relevance of active GSK3 in proliferation, migration, EMT induction and finally TLR3- and TLR4-induced inflammatory responses of HNSCC. The gene discussed is TLR4; the disease is head and neck squamous cell carcinoma.